HIV and haematopoiesis

Area of Science:

• Hematology
• Infectious Diseases
• Immunology

Background:

• Human immunodeficiency virus (HIV) infection compromises the immune system and disrupts normal blood cell production (hematopoiesis).
• Cytopenias, including anemia, thrombocytopenia, and neutropenia, are common complications of HIV infection, though their severity doesn't always correlate linearly with disease stage.
• The causes of these hematological abnormalities are multifactorial, involving drug toxicity, infections, malignancy, and direct effects of HIV on bone marrow.

Purpose of the Study:

• To review the frequencies of anemia, thrombocytopenia, and neutropenia in HIV-infected, treatment-naïve populations in eastern and southern sub-Saharan Africa.
• To outline a diagnostic approach for cytopenias in HIV-infected patients.
• To discuss the mechanisms by which HIV impacts hematopoietic stem/progenitor cells (HSPCs) leading to impaired hematopoiesis and cytopenias.

Main Methods:

• Literature review of studies reporting cytopenias in HIV-infected, treatment-naïve cohorts from eastern and southern sub-Saharan Africa.
• Analysis of diagnostic workup strategies for HIV-associated cytopenias.
• Review of existing research on HIV's direct and indirect effects on HSPCs and hematopoiesis.

Main Results:

• Frequencies of anemia, thrombocytopenia, and neutropenia in the specified cohorts are presented.
• A rational diagnostic approach for evaluating cytopenias in HIV-infected individuals is discussed.
• The review details how HIV directly and indirectly affects HSPCs, leading to defective hematopoiesis.

Conclusions:

• HIV infection significantly impacts hematopoiesis, leading to various cytopenias.
• Understanding the mechanisms of HIV-induced hematological dysfunction is crucial for patient management.
• Further research on managing cytopenias in HIV-infected individuals, particularly in sub-Saharan Africa, is warranted.